GlassScriptPhysician profile
Leo Maria Maher
NPI 1558396044
$382,094.32
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146K · 2020: $75K · 2021: $51K · 2022: $73K · 2023: $33K · 2024: $3,938.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28K · Food and Beverage: $5,332 · Travel and Lodging: $3,402 · Education: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,793.00 |
| Food and Beverage | $5,332.32 |
| Travel and Lodging | $3,401.58 |
| Education | $376.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $99,757.09 | 2019-2023 | Tysabri, Vumerity, Tecfidera |
| Emd Serono, INC. | $83,858.31 | 2019-2024 | Mavenclad |
| Genzyme Corporation | $39,996.92 | 2019-2024 | |
| Teva Pharmaceuticals USA, INC. | $23,236.36 | 2019-2022 | |
| Genentech USA, INC. | $20,954.11 | 2019-2023 | Ocrevus |
| Celgene Corporation | $20,022.72 | 2019-2023 | Zeposia |
| Biohaven Pharmaceuticals, INC. | $18,975.34 | 2021 | |
| Tg Therapeutics, INC. | $15,024.53 | 2022-2024 | Briumvi |
| Allergan, INC. | $12,524.10 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $9,980.58 | 2019-2023 | |
| Mallinckrodt Enterprises LLC | $9,764.33 | 2019 | |
| Abbvie INC. | $8,513.05 | 2019-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $8,134.69 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $3,506.26 | 2020-2022 | |
| Mallinckrodt Hospital Products INC. | $2,204.07 | 2020-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,006.43 | 2019 | |
| Alexion Pharmaceuticals, INC. | $1,089.27 | 2019-2023 | Ultomiris, Soliris |
| Horizon Therapeutics Plc | $667.30 | 2021-2023 | Uplizna |
| Genentech, INC. | $448.90 | 2023 | Ocrevus, Enspryng |
| Ani Pharmaceuticals, INC. | $446.97 | 2022-2023 | Purified Cortrophin Gel |
| Ucb, INC. | $348.08 | 2019-2024 | Fintepla |
| Pfizer INC. | $138.19 | 2023-2024 | |
| Acadia Pharmaceuticals INC | $116.93 | 2019-2020 | |
| Medtronic, INC. | $92.82 | 2022 | |
| Amgen INC. | $55.90 | 2019-2021 | |
| Acorda Therapeutics, INC | $52.13 | 2019-2022 | |
| Lilly USA, LLC | $38.56 | 2023-2024 | Reyvow, Emgality, Amyvid |
| Grifols USA, LLC | $23.05 | 2024 | Gamunex-C |
| Bausch Health US, LLC | $22.79 | 2024 | Aplenzin |
| Averitas Pharma INC. | $21.67 | 2024 | Qutenza |
| Banner Life Sciences, LLC | $19.75 | 2023 | |
| Jazz Pharmaceuticals INC. | $19.59 | 2021 | |
| Neurelis, INC. | $18.55 | 2021 | |
| Amneal Pharmaceuticals LLC | $14.98 | 2024 | Rytary |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leo Maher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.